// App-Quantinova.ai

1390 : Molecular Basis Of Minimal Residual Disease In Subtypes Of Pediatric B Cell Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Jitsuda Sitthi-Amorn

Principal Investigators

  • Betty Herrington

  • Gail Megason

  • Jeanette Pullen

  • Catherine Gordon

  • Shirley Hogan

  • Tejaswi Koganti

  • Chindo Hick

Medical Centers

  • Department of Pharmacy Practice, University of Mississippi, Jackson, MS

  • Division of Newborn Medicine, Department of Pediatrics, University of Mississippi Medical Center, Jackson, MS

  • Department of Radiology, University of Mississippi Medical Center, Jackson, MS

  • Univ of Mississippi Medcl Ctr, Jackson, MS

  • Division of Newborn Medicine, Department of Pediatrics, University of Mississippi Medical Center, Jackson, MS

  • Cancer Institute, University of Mississippi Medical Center, Jackson, MS.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Mismatch repair deficiency

  • Solid malignancies

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • B-cell lymphoma 2

  • Beclin-1

  • Paired box 5

  • Cyclin Dependent Kinase Inhibitor 2A

  • Retinoblastoma protein

  • ETV6-RUNX1

  • Histone-lysine N-methyltransferase 2A

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved